Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 24, 2025 · Filed Nov 25, 2025
An Annovis Bio director paid $117K out of pocket for Annovis Bio shares. 1 other person at Annovis Bio bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$116,598
Shares × reported transaction price
$100K–$500K
+1.1%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 4 earlier confirmed purchases
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
11 days after results of Nov 13, 2025, 112 days before results of Mar 16, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $4.09 on Nov 24, 2025, 235% above its 52-week low and 44% below its high, after a 146% rise over the previous 30 trading days
52-week range $1.22 (Apr 8, 2025) to $7.28 (Dec 2, 2024), 47% of the way up, from 250 adjusted closes. 30 trading days earlier: $1.66 on Oct 13, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −5.5% | +0.6% | −6.1% |
| 30 days | −26.8% | +1.6% | −28.4% |
| 90 days | −45.5% | +1.1% | −46.7% |
| 180 days | −58.1% | +10.4% | −68.6% |
Past results only. Not a forecast.
Insider buying
Traded Dec 8, 2025 · filed 1 day later
An Annovis Bio director paid $64K out of pocket for Annovis Bio shares.
Insider buying
Traded Dec 8, 2025 · filed 1 day later
An Annovis Bio director paid $130K out of pocket for Annovis Bio shares.
Insider buying
Traded Nov 24, 2025 · filed 1 day later
An Annovis Bio director paid $6.1K out of pocket for Annovis Bio shares. 1 other person at Annovis Bio bought some too, in the same month.
Michael B Hoffman, Director's past purchases, 90 days after disclosure: 7 buys, median −32.6 pts vs S&P 500, beat it 1 of 7 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
